The Molecular Pharming Market is gaining attention as biotechnology companies increasingly explore plants as platforms for producing pharmaceuticals, vaccines, antibodies, enzymes, and other valuable biological products. Molecular pharming uses genetically modified plants to produce target proteins, offering an alternative approach to conventional microbial and mammalian-cell manufacturing.

Growing demand for biologics and the need for scalable production technologies are supporting interest in plant-based expression systems. Advances in genetic engineering are also improving researchers' ability to introduce and regulate therapeutic genes in suitable plant hosts.

The technology has applications across pharmaceutical research, vaccine development, diagnostics, and industrial biotechnology. As biologics become increasingly important in modern healthcare, molecular pharming provides an additional platform for producing complex biological molecules.